The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

Senate confirms Stephen Hahn as FDA commissioner

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

The Senate Dec. 12 voted 72-18 to confirm Stephen Hahn as FDA commissioner.

Hahn, 59, is chief medical executive at MD Anderson Cancer Center and professor in the Department of Radiation Oncology.

On Dec. 3, members of the Senate Committee on Health Education Labor and Pensions voted 18-5 to confirm Hahn (The Cancer Letter, Dec. 6). The White House announced its intention to nominate Hahn Nov. 1 (The Cancer Letter, Sept. 6, Nov. 1).

In his Senate confirmation hearing Nov. 20, Hahn acknowledged that the rise in e-cigarette use among youths “is an important, urgent crisis in this country,” but made no specific pledges as Democratic and Republican Senate members pressed him on whether he would resist pressure from the administration and lobbying groups. (The Cancer Letter, Nov. 22).

Once sworn in, Hahn will become the 24th FDA commissioner, succeeding Scott Gottlieb.

Table of Contents

YOU MAY BE INTERESTED IN

Guest Editorial

When “safe and effective” is not “reasonable and necessary”
We can curb excessive drug dosing and improve the quality of cancer care

By law, the Food and Drug Administration is required to determine whether a drug, device, biologic, or medical device is “safe and effective.” But the FDA determination does not control whether the Centers for Medicare & Medicaid Services will pay for it.  To satisfy CMS, medical products and services must be “reasonable and necessary,” meaning...

By Mark J. Ratain and David A. Hyman
ClinicalTrials & Tribulations

A radiation oncologist’s perspective: Why we need to accelerate early detection strategies for lung cancers

As a radiation oncologist, I am struck by how often the decisive variable in lung cancer is not the sophistication of our therapy, but the timing of our encounter with the disease.  The American Cancer Society projects 618,120 cancer deaths in the United States in 2025, with lung cancer remaining as the single largest contributor,...

By Kevin King
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account